flumazenil and lormetazepam

flumazenil has been researched along with lormetazepam in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19905 (45.45)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Doenicke, A; Greim, M; Juhl, G; Rampf, U; Suttmann, H1
Klotz, U1
Ackenheil, M; Doenicke, A; Dorow, R; Duka, T; Noderer, J1
Berenberg, D; Dorow, R; Duka, T; Sauerbrey, N1
Benkert, O; Heuser, I; Wetzel, H1
Doenicke, A; Dorow, R; Duka, T; Klotz, U1
Avanzini, P; Caccavari, R; Chittolini, B; Delsignore, R; Fertonani, G; Gerra, G; Giucasto, G; Zaimovic, A1

Trials

5 trial(s) available for flumazenil and lormetazepam

ArticleYear
[Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
    EEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete, 1990, Volume: 21, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Beta Rhythm; Diazepam; Dose-Response Relationship, Drug; Electroencephalography; Flumazenil; Flunitrazepam; Humans; Injections, Intravenous; Lorazepam; Male; Midazolam; Prospective Studies; Randomized Controlled Trials as Topic; Stimulation, Chemical

1990
Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.
    Psychopharmacology, 1986, Volume: 90, Issue:3

    Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Blood Pressure; Double-Blind Method; Electrocardiography; Electroencephalography; Flumazenil; Flunitrazepam; Humans; Lorazepam; Male; Norepinephrine; Random Allocation

1986
Amnestic effects of lormetazepam and their reversal by the benzodiazepine antagonist Ro 15-1788.
    Psychopharmacology, 1987, Volume: 93, Issue:4

    Topics: Adult; Amnesia; Anti-Anxiety Agents; Benzodiazepines; Cognition; Emotions; Female; Flumazenil; Humans; Lorazepam; Male; Memory

1987
Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    British journal of clinical pharmacology, 1985, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Flumazenil; Flunitrazepam; Humans; Kinetics; Lorazepam; Male

1985
Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    International clinical psychopharmacology, 1996, Volume: 11, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Flumazenil; GABA Modulators; Humans; Injections, Intravenous; Lorazepam; Male; Substance Withdrawal Syndrome

1996

Other Studies

6 other study(ies) available for flumazenil and lormetazepam

ArticleYear
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Drug interactions and clinical pharmacokinetics of flumazenil.
    European journal of anaesthesiology. Supplement, 1988, Volume: 2

    Topics: Anti-Anxiety Agents; Benzodiazepines; Biological Availability; Drug Interactions; Ethanol; Flumazenil; Flunitrazepam; Half-Life; Humans; Liver; Lorazepam; Midazolam; Receptors, GABA-A; Tomography, Emission-Computed

1988
Benzodiazepines for catatonic symptoms, stupor, and mutism.
    Pharmacopsychiatry, 1988, Volume: 21, Issue:6

    Topics: Anti-Anxiety Agents; Benzodiazepines; Catatonia; Depressive Disorder; Diazepam; Female; Flumazenil; Humans; Lorazepam; Mutism

1988